123 related articles for article (PubMed ID: 22292965)
1. Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis.
Sultana S; Talegaonkar S; Ali R; Mittal G; Ahmad FJ; Bhatnagar A
J Microencapsul; 2012; 29(5):445-54. PubMed ID: 22292965
[TBL] [Abstract][Full Text] [Related]
2. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
[TBL] [Abstract][Full Text] [Related]
3. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
Cruz L; Assumpção E; Andrade SF; Conrado DJ; Kulkamp IC; Guterres SS; Pohlmann AR
Eur J Pharm Sci; 2010 Aug; 40(5):441-7. PubMed ID: 20471479
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles.
Kawakami K; Sumitani C; Yoshihashi Y; Yonemochi E; Terada K
Int J Pharm; 2010 May; 390(2):250-9. PubMed ID: 20170721
[TBL] [Abstract][Full Text] [Related]
6. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.
Abdelbary AA; Al-mahallawi AM; Abdelrahim ME; Ali AM
Int J Nanomedicine; 2015; 10():6339-53. PubMed ID: 26491298
[TBL] [Abstract][Full Text] [Related]
7. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation.
Lebhardt T; Roesler S; Uusitalo HP; Kissel T
Eur J Pharm Biopharm; 2011 May; 78(1):90-6. PubMed ID: 21145394
[TBL] [Abstract][Full Text] [Related]
8. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
Cohen-Sela E; Chorny M; Koroukhov N; Danenberg HD; Golomb G
J Control Release; 2009 Jan; 133(2):90-5. PubMed ID: 18848962
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery.
Cruz L; Fattal E; Tasso L; Freitas GC; Carregaro AB; Guterres SS; Pohlmann AR; Tsapis N
J Control Release; 2011 Jun; 152(3):370-5. PubMed ID: 21396412
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice.
Duret C; Wauthoz N; Merlos R; Goole J; Maris C; Roland I; Sebti T; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2012 Aug; 81(3):627-34. PubMed ID: 22538097
[TBL] [Abstract][Full Text] [Related]
11. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization.
Matteucci ME; Hotze MA; Johnston KP; Williams RO
Langmuir; 2006 Oct; 22(21):8951-9. PubMed ID: 17014140
[TBL] [Abstract][Full Text] [Related]
12. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Wang Y; Kho K; Cheow WS; Hadinoto K
Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-assisted transdermal delivery of alendronate for the treatment of osteoporosis.
Li B; Huang G; Ma Z; Qin S
Acta Biochim Pol; 2020 Jun; 67(2):173-179. PubMed ID: 32558528
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
Minne A; Boireau H; Horta MJ; Vanbever R
Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
[TBL] [Abstract][Full Text] [Related]
15. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
16. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
[TBL] [Abstract][Full Text] [Related]
17. Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated release.
Zhu X; Gu J; Wang Y; Li B; Li Y; Zhao W; Shi J
Chem Commun (Camb); 2014 Aug; 50(63):8779-82. PubMed ID: 24967656
[TBL] [Abstract][Full Text] [Related]
18. Influence of electrolyte and poloxamer 188 on the aggregation kinetics of solid lipid nanoparticles (SLNs).
Wei CC; Ge ZQ
Drug Dev Ind Pharm; 2012 Sep; 38(9):1084-9. PubMed ID: 22181005
[TBL] [Abstract][Full Text] [Related]
19. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
Le VN; Robins E; Flament MP
Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
[TBL] [Abstract][Full Text] [Related]
20. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations.
Donovan MJ; Smyth HD
Int J Pharm; 2010 Dec; 402(1-2):1-9. PubMed ID: 20816928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]